Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The PROACT LUNG Study: A Prospective, Observational,Clinical Validation Study of the Freenome Multiomics Blood Test for Lung Cancer Screening (FRNM-007)

NCT06122077 is registered in ClinicalTrials.gov with Freenome Holdings Inc. as lead sponsor.

NCT NCT06122077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06122077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The PROACT LUNG Study: A Prospective, Observational,Clinical Validation Study of the Freenome Multiomics Blood Test for Lung Cancer Screening (FRNM-007)
Lead sponsor
Freenome Holdings Inc.
Phase
Observational
Overall status
Recruiting
Start date
November 28, 2023
Completion date
June 15, 2027
Enrollment
20,000 (estimated)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer diagnosis